Eric Halioua, President & CEO of PDC*line Pharma will present the company at Bio€quity Europe, May 14 – 16, 2018 in Ghent, Belgium.

Flanders.bio’s flagship event knowledge for growth will be organized back to back with the 19th edition of the prestigious Bio€quity conference.

PDC*line Pharma CEO and COO will be in Amsterdam (The Netherlands), March 12–14, 2018 for the BIO-EUROPE SPRING 12th annual international partnering conference. Contact us for a face to face meeting through the partnering module of the conference.

Eric Halioua, President & CEO of PDC*line Pharma will be a panelist in the Advances in Cell & Gene Therapies round table at the 11th Annual European Life Sciences CEO Forum. A Sachs Associates event organized, Feb. 27, 2018 in Hilton Zurich Airport Hotel (Switzerland).

PDC*line Pharma CMO and CSO will be present at ESMO Immuno Oncology Congress in Geneva, Switzerland – 07 Dec – 10 Dec 2017. A poster will be presented describing our last results with Neo-Antigens. Title of the abstract is: “PDC*vac: a powerful platform for priming and expanding Neo-Antigen specific-T cells”.

There is a paradigm shift in the treatment of cancer with recent research demonstrating that the immune system has tremendous potential to destroy tumours. Is immuno-oncology the new era of cancer medicine?